| Q38433785 | A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit |
| Q48346436 | Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts. |
| Q46987556 | Association between vestibuloocular reflex suppression during smooth movements of the head and attention deficit in progressive supranuclear palsy. |
| Q33831798 | Brain Magnetic Resonance Imaging (MRI) as a Potential Biomarker for Parkinson's Disease (PD). |
| Q47657093 | Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features |
| Q34560776 | Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy |
| Q84333494 | Clinical vignettes in Parkinson's disease: a collection of unusual medication-induced hallucinations, delusions, and compulsive behaviours |
| Q81803941 | Constraint-induced movement therapy in Parkinson's disease |
| Q33330781 | ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand |
| Q28479192 | Elevated pontine and putamenal GABA levels in mild-moderate Parkinson disease detected by 7 tesla proton MRS |
| Q48894050 | Gaze control and foot kinematics during stair climbing: characteristics leading to fall risk in progressive supranuclear palsy. |
| Q43784629 | Gaze-shift strategies during functional activity in progressive supranuclear palsy. |
| Q33350248 | Haptic perception of object curvature in Parkinson's disease |
| Q48619185 | High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. |
| Q35752480 | Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms |
| Q71545737 | Idiopathic generalized myokymia (Isaacs' syndrome) with hand posturing resembling dystonia |
| Q84786468 | Inferior olive response to passive tactile and visual stimulation with variable interstimulus intervals |
| Q52581970 | Interval timing and Parkinson's disease: heterogeneity in temporal performance. |
| Q38695637 | Magnetic resonance imaging as a potential biomarker for Parkinson's disease. |
| Q35977276 | Magnetization transfer and adiabatic R 1ρ MRI in the brainstem of Parkinson's disease |
| Q93128426 | Motor phenotype classification in moderate to advanced PD in BioFIND study |
| Q47193843 | Multi-modal Brain MRI in Subjects with PD and iRBD. |
| Q33622086 | Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification |
| Q37603362 | N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases. |
| Q83969366 | Novel mutations in siblings with later-onset PLA2G6-associated neurodegeneration (PLAN) |
| Q73815722 | POEMS syndrome in a 24-year-old man associated with vitamin B12 deficiency and a solitary lytic bone lesion |
| Q48589905 | Perception of heaviness in Parkinson's disease. |
| Q46891214 | Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: detection of high GABA concentrations. |
| Q35781935 | Selective impairments in implicit learning in Parkinson's disease |
| Q28076121 | The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort |
| Q42971069 | The effect of dopamine replacement therapy on haptic sensitivity in Parkinson's disease. |
| Q35487243 | The effect of subthalamic nucleus stimulation on kinaesthesia in Parkinson's disease |
| Q34546834 | The evaluation and management of patients with neuroleptic malignant syndrome. |
| Q51917738 | The perception of passive motion in Parkinson's disease. |